Onconetix, Inc. — Form 10-Q
Filed November 16, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
David Allan White (CEO) and Karina M. Fedasz (CFO) issued standard Sarbanes-Oxley certifications on November 16, 2026 for the quarterly period ended September 30, 2026. Both officers certified that the 10-Q filing contains no untrue material statements, that financial statements fairly present the company's condition and operations, and that disclosure controls and internal controls over financial reporting are designed and operating effectively. No material weaknesses, significant deficiencies, or fraud disclosures were noted.
Why this rating
Routine SOX certification exhibits; standard periodic disclosure with no material issues flagged. Boilerplate content, immaterial to business trajectory.
See more from November 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.